BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 33508376)

  • 1. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
    Bettinger D; Sturm L; Pfaff L; Hahn F; Kloeckner R; Volkwein L; Praktiknjo M; Lv Y; Han G; Huber JP; Boettler T; Reincke M; Klinger C; Caca K; Heinzow H; Seifert LL; Weiss KH; Rupp C; Piecha F; Kluwe J; Zipprich A; Luxenburger H; Neumann-Haefelin C; Schmidt A; Jansen C; Meyer C; Uschner FE; Brol MJ; Trebicka J; Rössle M; Thimme R; Schultheiss M
    J Hepatol; 2021 Jun; 74(6):1362-1372. PubMed ID: 33508376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FIPS Score for Prediction of Survival After TIPS Placement: External Validation and Comparison With Traditional Risk Scores in a Cohort of Chinese Patients With Cirrhosis.
    Yang C; Chen Q; Zhou C; Liu J; Huang S; Wang Y; Wang C; Ju S; Chen Y; Li T; Bai Y; Yao W; Xiong B
    AJR Am J Roentgenol; 2022 Aug; 219(2):255-267. PubMed ID: 35138134
    [No Abstract]   [Full Text] [Related]  

  • 3. Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question.
    Pitton MB; Zimmermann T; Mildenberger P; Weinmann A; Kloeckner R; Düber C; Mittler J; Hoppe-Lotichius M; Otto G
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e214-e222. PubMed ID: 33230020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
    Membreno F; Baez AL; Pandula R; Walser E; Lau DT
    J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validating the prognostic value of Freiburg index of posttransjugular intrahepatic portosystemic shunt survival score and classic scores in Chinese patients with implantation of transjugular intrahepatic portosystemic shunt.
    Song J; Wang X; Yan Y; Xiang T; Luo X
    Eur J Gastroenterol Hepatol; 2022 Oct; 34(10):1074-1080. PubMed ID: 36062497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
    Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
    Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantation of transjugular intrahepatic portosystemic shunt (TIPS): indication and patient selection.
    Bettinger D; Thimme R; Schultheiß M
    Curr Opin Gastroenterol; 2022 May; 38(3):221-229. PubMed ID: 35471813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of artificial intelligence for prognostic prediction with the albumin-bilirubin and platelet-albumin-bilirubin for cirrhotic patients with acute variceal bleeding undergoing early transjugular intrahepatic portosystemic shunt.
    Zhong BY; Tang HH; Wang WS; Shen J; Zhang S; Li WC; Yin Y; Yang J; Liu F; Ni CF; Zhao JB; Zhu XL
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e153-e160. PubMed ID: 33177378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.
    Strunk H; Marinova M
    Rofo; 2018 Aug; 190(8):701-711. PubMed ID: 30045395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian network-based survival prediction model for patients having undergone post-transjugular intrahepatic portosystemic shunt for portal hypertension.
    Chen R; Luo L; Zhang YZ; Liu Z; Liu AL; Zhang YW
    World J Gastroenterol; 2024 Apr; 30(13):1859-1870. PubMed ID: 38659484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15.
    Ascha M; Hanouneh M; S Ascha M; Zein NN; Sands M; Lopez R; Hanouneh IA
    Dig Dis Sci; 2017 Feb; 62(2):534-542. PubMed ID: 27154510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model.
    Vizzutti F; Celsa C; Calvaruso V; Enea M; Battaglia S; Turco L; Senzolo M; Nardelli S; Miraglia R; Roccarina D; Campani C; Saltini D; Caporali C; Indulti F; Gitto S; Zanetto A; Di Maria G; Bianchini M; Pecchini M; Aspite S; Di Bonaventura C; Citone M; Guasconi T; Di Benedetto F; Arena U; Fanelli F; Maruzzelli L; Riggio O; Burra P; Colecchia A; Villa E; Marra F; Cammà C; Schepis F
    Hepatology; 2023 Feb; 77(2):476-488. PubMed ID: 35921493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding.
    Walter A; Rudler M; Olivas P; Moga L; Trépo E; Robic MA; Ollivier-Hourmand I; Baiges A; Sutter O; Bouzbib C; Peron JM; Le Pennec V; Ganne-Carrié N; Garcia-Pagán JC; Mallet M; Larrue H; Dao T; Thabut D; Hernández-Gea V; Nault JC; Bureau C; Allaire M;
    Hepatology; 2021 Oct; 74(4):2085-2101. PubMed ID: 34018627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.
    Nicoară-Farcău O; Han G; Rudler M; Angrisani D; Monescillo A; Torres F; Casanovas G; Bosch J; Lv Y; Thabut D; Fan D; Hernández-Gea V; García-Pagán JC;
    Gastroenterology; 2021 Jan; 160(1):193-205.e10. PubMed ID: 32980344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation.
    Gaba RC; Couture PM; Bui JT; Knuttinen MG; Walzer NM; Kallwitz ER; Berkes JL; Cotler SJ
    J Vasc Interv Radiol; 2013 Mar; 24(3):411-20, 420.e1-4; quiz 421. PubMed ID: 23312989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures.
    Maleux G; Nevens F; Wilmer A; Heye S; Verslype C; Thijs M; Wilms G
    Eur Radiol; 2004 Oct; 14(10):1842-50. PubMed ID: 15221261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study.
    Lv Y; Zuo L; Zhu X; Zhao J; Xue H; Jiang Z; Zhuge Y; Zhang C; Sun J; Ding P; Ren W; Li Y; Zhang K; Zhang W; He C; Zhong J; Peng Q; Ma F; Luo J; Zhang M; Wang G; Sun M; Dong J; Bai W; Guo W; Wang Q; Yuan X; Wang Z; Yu T; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Li K; Yin Z; Nie Y; Fan D; Han G
    Gut; 2019 Jul; 68(7):1297-1310. PubMed ID: 30415233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience.
    Cui J; Smolinski SE; Liu F; Xu D; Dulaimy K; Irani Z
    AJR Am J Roentgenol; 2018 Feb; 210(2):438-446. PubMed ID: 29261352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures.
    Lee BT; Yang AH; Urban S; Kim KY; Ter-Oganesyan R; Yuan L; Han HH; Khemichian S; Kahn JA; Kim B
    Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):541-546. PubMed ID: 32398491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.
    Dissegna D; Sponza M; Falleti E; Fabris C; Vit A; Angeli P; Piano S; Cussigh A; Cmet S; Toniutto P
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):626-632. PubMed ID: 30550458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.